Recursion Pharmaceuticals, Inc. (RXRX)
NASDAQ: RXRX · Real-Time Price · USD
6.43
-0.11 (-1.68%)
At close: Jul 23, 2025, 4:00 PM
6.52
+0.09 (1.34%)
After-hours: Jul 23, 2025, 7:59 PM EDT
Recursion Pharmaceuticals Analyst Ratings
Total Analysts
5
Consensus Rating
Buy
Price Target
$7.00
Upside
+8.86%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Needham | Needham | Strong Buy Reiterates $8 | Strong Buy | Reiterates | $8 | +24.42% | Jul 8, 2025 |
| Morgan Stanley | Morgan Stanley | Hold Initiates $5 | Hold | Initiates | $5 | -22.24% | Jul 3, 2025 |
| Morgan Stanley | Morgan Stanley | Hold Maintains $8 → $5 | Hold | Maintains | $8 → $5 | -22.24% | Jun 16, 2025 |
| Needham | Needham | Strong Buy Maintains $11 → $8 | Strong Buy | Maintains | $11 → $8 | +24.42% | May 6, 2025 |
| Morgan Stanley | Morgan Stanley | Hold Maintains $10 → $8 | Hold | Maintains | $10 → $8 | +24.42% | Apr 10, 2025 |
| Needham | Needham | Strong Buy Reiterates $11 | Strong Buy | Reiterates | $11 | +71.07% | Apr 8, 2025 |
| Leerink Partners | Leerink Partners | Hold Maintains $7 → $6 | Hold | Maintains | $7 → $6 | -6.69% | Feb 28, 2025 |
| Needham | Needham | Strong Buy Reiterates $11 | Strong Buy | Reiterates | $11 | +71.07% | Feb 6, 2025 |
| Keybanc | Keybanc | Buy Maintains $12 → $10 | Buy | Maintains | $12 → $10 | +55.52% | Jan 8, 2025 |
| Needham | Needham | Strong Buy Reiterates $11 | Strong Buy | Reiterates | $11 | +71.07% | Dec 11, 2024 |
| Needham | Needham | Strong Buy Reiterates $11 | Strong Buy | Reiterates | $11 | +71.07% | Nov 20, 2024 |
| Needham | Needham | Strong Buy Reiterates $11 | Strong Buy | Reiterates | $11 | +71.07% | Nov 7, 2024 |
| Needham | Needham | Strong Buy Maintains $16 → $11 | Strong Buy | Maintains | $16 → $11 | +71.07% | Sep 4, 2024 |
| Jefferies | Jefferies | Hold Maintains $8 → $6 | Hold | Maintains | $8 → $6 | -6.69% | Sep 3, 2024 |
| Leerink Partners | Leerink Partners | Hold Maintains $9 → $8 | Hold | Maintains | $9 → $8 | +24.42% | Sep 3, 2024 |
| Needham | Needham | Strong Buy Maintains $17 → $16 | Strong Buy | Maintains | $17 → $16 | +148.83% | Aug 9, 2024 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.